Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses
Circulation Journal · 2024
DOI: 10.1253/circj.cj-24-0135 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation Journal, 2024. Verfasst von Naoki Fujimura und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Saiseikai Central Hospital. Hauptthemen laut MEDLINE: Blood Vessel Prosthesis, Femoral Artery, Heparin, Peripheral Arterial Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Despite the widespread use of PROPATEN®, a bioactive heparin-bonded expanded polytetrafluoroethylene graft, in bypass surgery, there are only a few reports of long-term results. We evaluated the long-term results of PROPATEN®use for above-knee femoropopliteal bypass (AKFPB). METHODS AND RESULTS: After PROPATEN®-based AKFPB, patients were prospectively registered at 20 Japanese institutions between July 2014 and October 2017 to evaluate long-term results. During the median follow-up of 76 months (interquartile range 36-88 months) for 120 limbs (in 113 patients; mean [±SD] age 72.7±8.1 years; 66.7% male; ankle-brachial index [ABI] 0.45±0.27; lesion length 26.2±5.7 cm; chronic limb-threatening ischemia in 45 limbs), there were 8 major amputations; however, clinical improvement was sustained (mean [±SD] ABI 0.87±0.23) and the Rutherford classification grade improved in 105 (87.5%) limbs at the latest follow-up. At 8 years, the primary patency, freedom from target-lesion revascularization, secondary patency, survival, and amputation-free survival, as estimated by the Kaplan-Meier method, were 66.3±4.8%, 71.5±4.4%, 86.5±3.4%, 53.1±5.0%, and 47.4±5.3%, respectively. CONCLUSIONS: This multicenter prospective registry-based analysis showed sustained excellent clinical improvement and secondary patency for up to 8 years following PROPATEN®-based AKFPB. PROPATEN®constitutes a durable and good revascularization option for complex superficial femoral artery lesions, especially when endovascular treatment is inappropriate or an adequate venous conduit is unavailable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, Saiseikai Central Hospital.
- Department of Surgery, Keio University School of Medicine.
- Department of Surgery, The Jikei University Kashiwa Hospital.
- Department of Surgery, Shonan Kamakura General Hospital.
- Department of Surgery, Narita Tomisato Tokushukai Hospital.
- Department of Surgery, Saitama Municipal Hospital.
Zitieren
APA
Fujimura, N., Obara, H., Matsubara, K., Toya, N., Isogai, N., Ogino, H., Fujii, T., Kudo, T., Kanaoka, Y., Harada, H., Uchiyama, H., Guntani, A., Shimogawara, T., Watada, S., Shibutani, S., Ohki, T., & Japanese Bypass Registry Group (2024). Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses. Circulation Journal. https://doi.org/10.1253/circj.cj-24-0135
Vancouver
Fujimura N, Obara H, Matsubara K, Toya N, Isogai N, Ogino H, et al. Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses. Circulation Journal. 2024. doi:10.1253/circj.cj-24-0135
BibTeX
@article{Fujimura2024,
author = {Fujimura, Naoki and Obara, Hideaki and Matsubara, Kentaro and Toya, Naoki and Isogai, Naoko and Ogino, Hidemitsu and Fujii, Taku and Kudo, Toshifumi and Kanaoka, Yuji and Harada, Hirohisa and Uchiyama, Hidetoshi and Guntani, Atsushi and Shimogawara, Tatsuya and Watada, Susumu and Shibutani, Shintaro and Ohki, Takao and Japanese Bypass Registry Group, Japanese Bypass Registry Group},
title = {Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses},
journal = {Circulation Journal},
year = {2024},
doi = {10.1253/circj.cj-24-0135}
}
EUVIMED